The 130th Annual Meeting of APHA

Abstract #52686

Martin T. Donahoe, MD FACP, Center for Ethics in Health Care, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098, N/A, anna.keller@apha.org

Learning Objectives:

• Assess the role of industry in funding basic science and clinical investigation related to drug development.
• Articulate ethical issues which arise consequent to increasing links between academia and industry.
• Develop recommendations for effective investigator-industry, policy maker-industry, and provider-industry relationships.
• Articulate ways in which health professionals can work collaboratively with industry to benefit patients.

Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.